SK bioscience appoints new executives
Two biopharmaceutical experts join SK bioscience to strengthen the future strategies
Two biopharmaceutical experts join SK bioscience to strengthen the future strategies
OrbiMed's exercise of warrant conversion will further strengthen the company's net cash position to over Rs.650 crores.
Connectivity and harmonisation were both key driving factors behind our decision to choose the CARA Life Sciences Platform to consolidate our processes
This donation will allow the continuation of the cycle of vaccination for children foreseen within the national immunization program carried out by the Ministry of Public Health of Cuba
Under the soon to be launched Heal in India initiative, India aims to provide its health infrastructure for patients abroad and make it a global hub for medical and value-based healthcare for patients from across the world
The cardiomyopathies market in the 68M is set to grow at a CAGR of 12.1%
The company was chosen for this transformative exercise due to its deep expertise in the healthcare vertical, coupled with its digital engineering and cloud capabilities, a vast partner network, and long-term relationship with the client
The company has played an important role in the procurement and distribution of emergency medical supplies supporting the Union Health Ministry for Covid–19 pandemic management
Dr. Grant brings to the table significant BOD governance, global business development, and corporate development expertise
Subscribe To Our Newsletter & Stay Updated